2009
DOI: 10.1016/j.worlddev.2009.01.002
|View full text |Cite
|
Sign up to set email alerts
|

Product Cycles, Innovation, and Exports: A Study of Indian Pharmaceuticals

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

2
39
0
3

Year Published

2012
2012
2022
2022

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 53 publications
(44 citation statements)
references
References 33 publications
2
39
0
3
Order By: Relevance
“…Within international markets, firms face an acute competition, rapid technological changes and more difficulties in obtaining important know-how (Teece, 2007). The intensity of global competition, shorter product life cycles, accelerate product research and development, and the easiness of imitation impel exporting firms to innovation activity as a way to ensure their competitiveness (Chadha, 2009;Roper & Love, 2002;Salomon & Shaver, 2005a). Innovation is critical for the firms' survival and long-term success (Evangelista et al, 1997;O'Regan et al, 2006;Yam et al, 2004).…”
Section: Introductionmentioning
confidence: 99%
“…Within international markets, firms face an acute competition, rapid technological changes and more difficulties in obtaining important know-how (Teece, 2007). The intensity of global competition, shorter product life cycles, accelerate product research and development, and the easiness of imitation impel exporting firms to innovation activity as a way to ensure their competitiveness (Chadha, 2009;Roper & Love, 2002;Salomon & Shaver, 2005a). Innovation is critical for the firms' survival and long-term success (Evangelista et al, 1997;O'Regan et al, 2006;Yam et al, 2004).…”
Section: Introductionmentioning
confidence: 99%
“…Some researchers have also used the Indian pharmaceutical industry to investigate the impact of patent policy changes. Chadha () found that the patenting activity of the pharmaceutical firms increased after the TRIPs agreement. Mahajan () found the patent policy changes resulted in increased R&D efforts.…”
Section: Literature Reviewmentioning
confidence: 99%
“…From a socio-legal perspective, Gostin [102] provides a critical analysis of current global health architecture and need for change in order to meet basic health needs and to ensure greater country ownership and autonomy within health. With regards to TRIPS, common themes were the analysis of implications of new patent laws on access to medicines, particularly antiretrovirals [103,104] and of the emerging opportunities and challenges for pharmaceutical industries [105-110]. Papers consider how India has responded to TRIPS, how patent policies have been amended and implemented within India, and to what extent innovation and research and development has been stimulated following increased patent protection.…”
Section: Introductionmentioning
confidence: 99%
“…There were two microeconomic analyses. Fink [107] calibrates a theoretical model with data from the pharmaceutical industry in India to simulate the possible impact of stronger patent policies on transnational corporations and in turn on market and welfare impacts, and Chadha [105] draws on product cycle and neo-technology theories of trade to analyse export performance of 131 Indian pharmaceutical companies.…”
Section: Introductionmentioning
confidence: 99%